Semin Arthritis Rheu:血清球蛋白间隙升高是全身性风湿病血沉升高的可靠标志物

2019-12-23 xiangting MedSci原创

在球蛋白间隙升高的全身性风湿病患者亚组中,ESR总是升高的。

血清C反应蛋白(CRP)水平和红细胞沉降率(ESR)是临床实践中最常用的两种炎症标志物。减少这些测试的需求可以在不牺牲患者治疗质量的情况下节约大量成本。

研究人员回顾性分析了20155月至20176月在一个学术医疗中心的风湿病诊所就诊的全身性风湿病患者的电子病历。确定了血清CRP水平与ESR vs血清球蛋白间隙(总蛋白与白蛋白水平的差值)和白球比(AG)的相关性以及受试者工作特征(ROC)曲线。

在两个独立队列中(发现队列:263名受试者,446次测试;验证队列:438名受试者,1959次测试),球蛋白间隙和AG比值与CRP水平和ESR 相关(p<0.001),ESR的相关系数大于CRPROC曲线分析显示,ESR的曲线下面积比CRP曲线下面积更好。球蛋白间隙升高(≥4.0g/dl)和AG比值降低(<0.8)测试所占百分比分别为8.4%和2.6%,并且对ESR升高的阳性预测值均≥0.960。在球蛋白间隙高的患者中,球蛋白间隙随时间的变化忠实地反映了ESR的变化。

在球蛋白间隙升高的全身性风湿病患者亚组中,ESR总是升高的。这一新发现为随后评估在不牺牲患者治疗质量的情况下,是否可以减少这部分风湿病患者ESR检测的前瞻性研究奠定了概念基础和理论基础。最终,可能不需要进行ESR检测,从而节省了成本。

原始出处:

William Stohl. Elevated serum globulin gap as a highly reliable marker of elevated erythrocyte sedimentation rate in patients with systemic rheumatic diseases. Semin Arthritis Rheu. December 2019.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1972686, encodeId=f05c19e268622, content=<a href='/topic/show?id=8a6a2e8839' target=_blank style='color:#2F92EE;'>#Arthritis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2788, encryptionId=8a6a2e8839, topicName=Arthritis)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Sun Feb 23 13:07:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035207, encodeId=d80e203520ec9, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68667, encryptionId=5a426866eae, topicName=球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sun May 10 03:07:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1841457, encodeId=3429184145e01, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sun Apr 12 11:07:00 CST 2020, time=2020-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798209, encodeId=73f81e98209f2, content=<a href='/topic/show?id=4aa368668c3' target=_blank style='color:#2F92EE;'>#球蛋白间隙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68668, encryptionId=4aa368668c3, topicName=球蛋白间隙)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2f42500210, createdName=12498ef1m31(暂无昵称), createdTime=Sat Feb 15 18:07:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357340, encodeId=326c135e340de, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Dec 25 01:07:00 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535088, encodeId=f0801535088c3, content=<a href='/topic/show?id=96228915477' target=_blank style='color:#2F92EE;'>#血沉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89154, encryptionId=96228915477, topicName=血沉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a5a12588790, createdName=neizongke, createdTime=Wed Dec 25 01:07:00 CST 2019, time=2019-12-25, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1972686, encodeId=f05c19e268622, content=<a href='/topic/show?id=8a6a2e8839' target=_blank style='color:#2F92EE;'>#Arthritis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2788, encryptionId=8a6a2e8839, topicName=Arthritis)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Sun Feb 23 13:07:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035207, encodeId=d80e203520ec9, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68667, encryptionId=5a426866eae, topicName=球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sun May 10 03:07:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1841457, encodeId=3429184145e01, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sun Apr 12 11:07:00 CST 2020, time=2020-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798209, encodeId=73f81e98209f2, content=<a href='/topic/show?id=4aa368668c3' target=_blank style='color:#2F92EE;'>#球蛋白间隙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68668, encryptionId=4aa368668c3, topicName=球蛋白间隙)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2f42500210, createdName=12498ef1m31(暂无昵称), createdTime=Sat Feb 15 18:07:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357340, encodeId=326c135e340de, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Dec 25 01:07:00 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535088, encodeId=f0801535088c3, content=<a href='/topic/show?id=96228915477' target=_blank style='color:#2F92EE;'>#血沉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89154, encryptionId=96228915477, topicName=血沉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a5a12588790, createdName=neizongke, createdTime=Wed Dec 25 01:07:00 CST 2019, time=2019-12-25, status=1, ipAttribution=)]
    2020-05-10 xzw113
  3. [GetPortalCommentsPageByObjectIdResponse(id=1972686, encodeId=f05c19e268622, content=<a href='/topic/show?id=8a6a2e8839' target=_blank style='color:#2F92EE;'>#Arthritis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2788, encryptionId=8a6a2e8839, topicName=Arthritis)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Sun Feb 23 13:07:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035207, encodeId=d80e203520ec9, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68667, encryptionId=5a426866eae, topicName=球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sun May 10 03:07:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1841457, encodeId=3429184145e01, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sun Apr 12 11:07:00 CST 2020, time=2020-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798209, encodeId=73f81e98209f2, content=<a href='/topic/show?id=4aa368668c3' target=_blank style='color:#2F92EE;'>#球蛋白间隙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68668, encryptionId=4aa368668c3, topicName=球蛋白间隙)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2f42500210, createdName=12498ef1m31(暂无昵称), createdTime=Sat Feb 15 18:07:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357340, encodeId=326c135e340de, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Dec 25 01:07:00 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535088, encodeId=f0801535088c3, content=<a href='/topic/show?id=96228915477' target=_blank style='color:#2F92EE;'>#血沉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89154, encryptionId=96228915477, topicName=血沉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a5a12588790, createdName=neizongke, createdTime=Wed Dec 25 01:07:00 CST 2019, time=2019-12-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1972686, encodeId=f05c19e268622, content=<a href='/topic/show?id=8a6a2e8839' target=_blank style='color:#2F92EE;'>#Arthritis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2788, encryptionId=8a6a2e8839, topicName=Arthritis)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Sun Feb 23 13:07:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035207, encodeId=d80e203520ec9, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68667, encryptionId=5a426866eae, topicName=球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sun May 10 03:07:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1841457, encodeId=3429184145e01, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sun Apr 12 11:07:00 CST 2020, time=2020-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798209, encodeId=73f81e98209f2, content=<a href='/topic/show?id=4aa368668c3' target=_blank style='color:#2F92EE;'>#球蛋白间隙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68668, encryptionId=4aa368668c3, topicName=球蛋白间隙)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2f42500210, createdName=12498ef1m31(暂无昵称), createdTime=Sat Feb 15 18:07:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357340, encodeId=326c135e340de, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Dec 25 01:07:00 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535088, encodeId=f0801535088c3, content=<a href='/topic/show?id=96228915477' target=_blank style='color:#2F92EE;'>#血沉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89154, encryptionId=96228915477, topicName=血沉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a5a12588790, createdName=neizongke, createdTime=Wed Dec 25 01:07:00 CST 2019, time=2019-12-25, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1972686, encodeId=f05c19e268622, content=<a href='/topic/show?id=8a6a2e8839' target=_blank style='color:#2F92EE;'>#Arthritis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2788, encryptionId=8a6a2e8839, topicName=Arthritis)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Sun Feb 23 13:07:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035207, encodeId=d80e203520ec9, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68667, encryptionId=5a426866eae, topicName=球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sun May 10 03:07:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1841457, encodeId=3429184145e01, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sun Apr 12 11:07:00 CST 2020, time=2020-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798209, encodeId=73f81e98209f2, content=<a href='/topic/show?id=4aa368668c3' target=_blank style='color:#2F92EE;'>#球蛋白间隙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68668, encryptionId=4aa368668c3, topicName=球蛋白间隙)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2f42500210, createdName=12498ef1m31(暂无昵称), createdTime=Sat Feb 15 18:07:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357340, encodeId=326c135e340de, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Dec 25 01:07:00 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535088, encodeId=f0801535088c3, content=<a href='/topic/show?id=96228915477' target=_blank style='color:#2F92EE;'>#血沉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89154, encryptionId=96228915477, topicName=血沉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a5a12588790, createdName=neizongke, createdTime=Wed Dec 25 01:07:00 CST 2019, time=2019-12-25, status=1, ipAttribution=)]
    2019-12-25 zhaojie88
  6. [GetPortalCommentsPageByObjectIdResponse(id=1972686, encodeId=f05c19e268622, content=<a href='/topic/show?id=8a6a2e8839' target=_blank style='color:#2F92EE;'>#Arthritis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2788, encryptionId=8a6a2e8839, topicName=Arthritis)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Sun Feb 23 13:07:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035207, encodeId=d80e203520ec9, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68667, encryptionId=5a426866eae, topicName=球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sun May 10 03:07:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1841457, encodeId=3429184145e01, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Sun Apr 12 11:07:00 CST 2020, time=2020-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798209, encodeId=73f81e98209f2, content=<a href='/topic/show?id=4aa368668c3' target=_blank style='color:#2F92EE;'>#球蛋白间隙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68668, encryptionId=4aa368668c3, topicName=球蛋白间隙)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2f42500210, createdName=12498ef1m31(暂无昵称), createdTime=Sat Feb 15 18:07:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357340, encodeId=326c135e340de, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Dec 25 01:07:00 CST 2019, time=2019-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1535088, encodeId=f0801535088c3, content=<a href='/topic/show?id=96228915477' target=_blank style='color:#2F92EE;'>#血沉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89154, encryptionId=96228915477, topicName=血沉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a5a12588790, createdName=neizongke, createdTime=Wed Dec 25 01:07:00 CST 2019, time=2019-12-25, status=1, ipAttribution=)]
    2019-12-25 neizongke

相关资讯

Am J Gastroenterol:研究发现憩室病或与结肠粘膜炎症无关

研究认为,无症状或症状性憩室病均与结肠粘膜炎症无关

C反应蛋白:一个有内涵的指标

C反应蛋白(CRP)是啥?CRP是机体受到微生物入侵或组织损伤等炎症性刺激时肝细胞合成的急性相蛋白。注:急性时相反应包括感染、炎症及创伤时某些血清蛋白浓度的变化,这些蛋白除CRP外,还包括血清淀粉样蛋白A、纤维蛋白原、触珠蛋白、α1酸性糖蛋白、铜蓝蛋白、α1抗胰蛋白酶等。其中CRP在健康人血清中浓度很低(<5 mg/L),而在细菌感染或组织损伤时,其浓度显着升高,故被认为其最有价值。CPR能反应啥

Clin Chem:在弗雷明汉后代研究中心血管疾病风险评估中直接对照计算低密度脂蛋白胆固醇和c反应蛋白

循环LDL- c (LDL- c)和高敏感性c -反应蛋白(hsCRP)浓度升高是心血管疾病(CVD)的重要危险因素。本研究中,我们直接评估了LDL-C和hsCRP浓度,并与Framingham子代研究中的标准危险因素进行了比较。

Am J Gastroenterol:结肠粘膜炎症并非憩室病的致病因素

研究认为,憩室病与结肠粘膜炎症无关,症状性结肠憩室病的病因需要进一步研究。

Brit J Cancer:炎症因子与肿瘤风险研究

研究认为,炎症标志物升高患者的肿瘤风险增加,但炎症标记物对癌症诊断的敏感性很低,不能作为排除指标

Sci Rep:血清高敏C反应蛋白水平与阴茎勃起功能障碍相关性研究

炎症能够影响内皮功能并且与阴茎勃起功能障碍(ED)的恶化有关。因此,最近有研究人员在中国男性群体中调查了炎症标记高敏C反应蛋白(hs-CRP)与ED之间的相关性。研究包括了1515名参与者。研究发现,血清hs-CRP水平在ED患者中显著更高,并且随着患者ED程度的加重其水平恶性化增加(ptrend<0.001)。在调整后的多变量模型中,最高四分位hs-CRP水平与最低四分位hs-CRP水平患